Nominate an outstanding early-career pharmacy researcher for OPERA 2025 Nominations for OPERA 2025 are open until 16 February 2025.…
Government-funded trial will test psilocybin as treatment for opioid use disorder The project is one of four funded by the National Institute for Health and Care Research aimed at cutting harm from illegal drugs.…
From paper to practice: a pharmacy professional’s guide to critical appraisal tools A guide to the tools and checklists available to help critically appraise research papers.…
Why are some research papers cited more than others? A look back at highly cited papers in the RPS research journals, by Parastou Donyai, chief scientist at the Royal Pharmaceutical Society.…
Warp drive: conducting experiments in space allows speedy results Experiments in space with human tissue chips bring hope of discovering new ways of treating diseases back on Earth.…
How do we use science within the practice of pharmacy? The pick of the month’s academic papers from Parastou Donyai, chief scientist at the Royal Pharmaceutical Society.…
Statins offer cost-effective benefit for older people, study results suggest The researchers found that lifetime use of a standard statin therapy increased quality-adjusted life years by 0.24–0.70 per person.…
MHRA finds no link between GLP-1 receptor agonists and suicidal behaviour The regulator says it will continue to monitor the risk of severe psychiatric reactions and assess new data as they become available.…
Advantages and disadvantages of shorter antimicrobial courses An overview of the available evidence for shorter antimicrobial courses, including how this can be supported in practice and the potential positive impact on antimicrobial resistance.…
Government opens £400m investment programme to boost UK clinical trials The investment programme will increase the UK’s capacity for clinical trials and give researchers greater access to the latest equipment and technology, the government said.…
